Indeed, recent genetic studies have found that TREM2 mutations represent a significant genetic risk factor in Nasu-Hakola Disease (97), frontotemporal dementia (FTD) (98), Parkinson’s disease (PD) (99), and amyotrophic lateral sclerosis (ALS) (100). Here, TREM2 is linked to amyotrophic lateral sclerosis.